Advisory Services Network, LLC Fsd Pharma Inc. Transaction History

Advisory Services Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.91 - $1.35 $21 - $32	24 New	24 $0
Q1 2023 May 17, 2023	SELL	$0.77 - $1.81 $37 - $88	-49 Reduced 67.12%	24 $0
Q4 2022 Feb 13, 2023	BUY	$0.73 - $1.07 $53 - $78	73 New	73 $0
Q4 2021 Feb 14, 2022	SELL	$0.96 - $1.63 $9,670 - $16,418	-10,073 Closed	0 $0
Q1 2021 May 24, 2021	BUY	$1.65 - $3.87 $13,200 - $30,960	8,000 Added 385.91%	10,073 $19,000

Q4 2020 Feb 09, 2021	BUY	$1.36 - $2.7 $2,720 - $5,400	2,000 Added 2739.73%	2,073 $3,000
Q3 2020 Nov 16, 2020	BUY	$2.55 - $4.26 $186 - $310	73 New	73 $0
Q2 2020 Aug 10, 2020	SELL	$2.58 - $7.39 $188 - $539	-73 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.55 - $10.86 $186 - $792	73 New	73 $0

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.